India’s pharmaceutical company Zydus begins human trails for potential COVID vaccine

Srinagar: Indian pharmaceutical company Zydus on Wednesday said that it has started human studies for its potential COVID vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation, reports said.

According to a report by an international news agency Reuters, ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

The report added that in the human trials, Zydus will enroll over 1,000 subjects across multiple clinical study sites in India.

To Top